関連する実験動画
Updated: Jul 29, 2026

05:52
Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
急性心筋梗塞の適格な高齢患者に対する血栓解消療法
H M Krumholz1, J E Murillo, J Chen
1Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT 06520-8017, USA.
JAMA
|June 4, 1997
まとめ
心臓発作後,血栓駆除薬の治療を受ける資格のある多くの高齢患者は,治療を受けていません. 医師の判断は,省略ではなく,判断に影響を与え,時には証拠に反して,ケア改善の機会を示します.
科学分野:
- 心臓病学 心臓病学
- ゲリアトリック・メディシン (老年医学)
- 医療サービス 研究 医療サービス
背景:
- 血栓駆除薬療法は,急性心筋梗塞 (AMI) の重要な治療法である.
- 高齢者患者 (≥65歳) は,AMIで入院した有意な人口を表しています.
- この集団における血栓解消療法の使用に影響を与える要因を理解することは,ケアを最適化するために極めて重要です.
研究 の 目的:
- AMIで入院した高齢患者の血栓解消療法使用の相関性を特定する.
- 適格な高齢者において,血栓解消剤治療を中止する理由を調べる.
主な方法:
- メディカルチャートと行政データを活用した遡及的なコホート研究.
- 1992年5月から1993年5月までAMIを患った65歳以上のメディケア受給者3093人を対象とした調査.
- 753人の適格な患者を分析し,即時再血管化に推薦されなかった.
主要な成果:
- 対象となる高齢患者の56%は,血栓駆除剤の治療を受けなかった.
- 非治療の予測要因には,高齢化,胸痛の欠如,発症遅延 (>6時間),左束の分岐ブロック,および精神状態の変化が含まれる.
- 医者の文書では,治療を遅らせたり,老化したりすることが,治療を中止する主な理由とされている.
結論:
- 適格な高齢のAMI患者のかなりの割合は,血栓駆除剤の治療を受けていません.
- 治療に関する決定は,臨床的判断に基づいており,時には,特に高齢者に関して,証拠に基づいたガイドラインから逸脱しているようです.
- これらの発見は,急性心筋梗塞の管理におけるガイドライン遵守と患者ケアを改善するための潜在的な分野を強調しています.
関連する概念動画
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...

